15Mar

[Correspondence] and Parkinson’s diseaseā€”Authors’ reply

We thank Jansen and colleagues for their interest in our Article and for replicating the analysis of CHCHD2 variants using a large western European cohort from the International Parkinson's Disease Genomics Consortium (IPDGC). We reported three potentially pathogenic mutations (182C>T, Thr61Ile; 434G>A, Arg145Gln; and 300+5G>A) for autosomal dominant Parkinson's disease.1 Of these mutations, only Thr61Ile was confirmed to cosegregate in two independent families with autosomal dominant Parkinson's disease.

Ander nieuws

20May

[Comment] A new step towards targeting tau

Progressive supranuclear palsy is a rare neurodegenerative disease characterised by an axial parkins...

naar nieuwsitem

20May

[Review] CSF and blood biomarkers for Parkinson’s disease

In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urg...

naar nieuwsitem

22Apr

Parkinson’s disease patient: ‘I can walk… it’s really helped me’

Parkinson's disease patient Gail Jardine can walk more freely after having a spinal implant fit...

naar nieuwsitem